Tougher FDA Approval Process Weighs on Biotech Sector
The Paragon Report Provides Equity Research on MannKind and Celsion

FDA Approvals Expected to Put Apricus Bio on Profitable Path
August has been a huge month for San Diego-based Apricus Biosciences Inc.

FDA Watch: 6 Biotechs Awaiting FDA Drug Approvals in 2011
(Written by Alexander Crawford. FDA decision data sourced from RTT News, all other data sourced from Finviz.) 2011 has already been a solid year for FDA drug approvals. By late July, the FDA had already matched their 21 new drug approvals made in 2010 with AstraZeneca s blood-thinner Brilinta.